SCHEMBL5345391

SCHEMBL5345391

CCc1cccc(N(C(N)=O)c2ccc(Sc3ccc4[nH]c(NC(=O)OC)nc4c3)cc2)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.52
CYP1A2 P05177 5/20 0.52
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
NR1I2 O75469 1/20 0.52
MAPK14 Q16539 1/20 0.52
KDR P35968 4/20 0.45
TEK Q02763 4/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
MAPK1 P28482 2/20 0.44
HPGD P15428 2/20 0.44
TP53 P04637 1/20 0.44
KCNH2 Q12809 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
HIF1A Q16665 4/20 0.41
CYP2C19 P33261 1/20 0.41
TUBB4A P04350 1/20 0.41
TUBB P07437 1/20 0.41
TUBA3C P0DPH7 1/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5345013 0.88 LMNA (0.53) LMNACYP1A2MEN1KMT2ANR1I2
SCHEMBL5347366 0.86 LMNA (0.51) LMNACYP1A2MEN1KMT2ANR1I2
SCHEMBL5348772 0.86 LMNA (0.55) LMNACYP1A2MEN1KMT2ANR1I2
SCHEMBL5348318 0.83 LMNA (0.53) LMNACYP1A2MEN1KMT2ANR1I2
SCHEMBL5350252 0.82 TEK (0.50) LMNACYP1A2MEN1KMT2AKDR
SCHEMBL5348310 0.81 LMNA (0.51) LMNACYP1A2MEN1KMT2ANR1I2
SCHEMBL5345392 0.81 KDR (0.68) LMNACYP1A2MEN1KMT2ANR1I2
SCHEMBL5347358 0.79 LMNA (0.50) LMNACYP1A2MEN1KMT2ANR1I2
Fenbendazole SCHEMBL28193035 0.78 LMNA (0.76) LMNACYP1A2MEN1KMT2ANR1I2
Fenbendazole SCHEMBL166352 0.77 LMNA (0.82) LMNACYP1A2MEN1KMT2ANR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249600-A1 CHEMICAL COMPOUNDS CHEUNG MUI 2007-10-25 US claimed
US-20040082583-A1 Chemical compounds SMITHKLINE BEECHAM CORPORATION 2004-04-29 US claimed
US-20070249600-A1 CHEMICAL COMPOUNDS CHEUNG MUI 2007-10-25 US disclosed
US-7238813-B2 Chemical compounds SMITHKLINE BEECHAM CORPORATION (US) 2007-07-03 US disclosed
US-20040082583-A1 Chemical compounds SMITHKLINE BEECHAM CORPORATION 2004-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249600-A1 CHEMICAL COMPOUNDS TIE1, KDR, FLT4 LMNA 2801/4885CYP1A2 1291/4885MEN1 760/4885
US-20040082583-A1 Chemical compounds TIE1, KDR, FLT4 LMNA 2801/4885CYP1A2 1291/4885MEN1 760/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.